Similarly, Lezcano et al. observed a score of +4 in 92% of 100 metastatic melanoma cases [20], while Kaczorowski et al. reported PRAME expression in 75% of 248 cases using an 80% threshold [30]. This evidence concerns the gene PRAME and metastatic melanoma.